SOLACI Peripheral Registry Hits the 1000-Patient Mark

We are very proud to say that our multicenter, prospective research registry continues to grow by leaps and bounds.

We want to congratulate the 36 centers from the 9 participating countries and invite the entire community to join this research initiative that aims to collect data on the reality of lower limb angioplasty in Latin America, in order to unify criteria, draw conclusions, and develop strategies to improve daily practice for these procedures.

To be part of the SOLACI PERIPHERAL Registry or learn more about it, contact research@solaci.org

It should be noted that SOLACI Peripheral is a research program open to all centers in Latin America that may be willing to actively participate; in this sense, each participant center will have access to registry data in real time. Furthermore, participants will have authorship rights in all Registry publications and will secure the possibility of using Registry data for their own research projects. 

The benefits of participating

  1. Access our own database dedicated to lower limb angioplasty, with unified criteria across Latin American centers.
  2. Analyze outcomes in real time with data from your own center.
  3. Interact with centers across the region interested in promoting research and furthering publishing.
  4. Present SOLACI Peripheral outcomes at local and international events.
  5. Benefit from SOLACI Research assistance to develop your research projects and/or statistical analysis. 
  6. Work closely with SOLACI Research, who will oversee your progress weekly and will make sure all data be used correctly from start to finish, with annual (mandatory) followup.

Your participation is really important to SOLACI and to the entire SOLACI Peripheral Committee. We would be pleased and honored to have you join us in this important initiative.

To take part of SOLACI Peripheral Registry, please email us to: research@solaci.org


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Panama Sessions 2026 – Young Interventional Cardiologists Contest. Submit Your Case

The call for submissions is now open to participate in the Young Interventional Cardiologists Competition at the Panama 2026 Regional Meeting, which will take...

ACC 2026: SURViV Trial Results – Exclusive Presentation and Analysis with Dr. Dimytri Siqueira

Following the presentation of the SURViV trial in the Late Breaking Clinical Trials sessions at the American College of Cardiology Congress, Dr. Dimytri Siqueira...

SOLACI Technicians Webinar – Ultrasound Pulses + Calcium = Coronary Lithotripsy

The Latin American Society of Interventional Cardiology (SOLACI) invites you to participate in a new Live SOLACI Webinar specially designed for technicians, nurses, and...

COMPLICAT 2026: Collaborative learning to address complications in congenital and structural heart disease

Free online course in Spanish5 webinars in 2026 COMPLICAT 2026 returns with its second edition, consolidating itself as an innovative academic space dedicated to the...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2026 | ALL-RISE Trial: Coronary Physiological Assessment Using FFRangio

Coronary physiological assessment using pressure-wire techniques (FFR/iFR) carries a Class IA recommendation in ACC/AHA guidelines; however, its use remains limited due to factors such...

ACC 2026 | Protect The Head-To-Head Trial: Randomized Comparison Between Emboliner and Sentinel During TAVI

Ischemic stroke remains one of the most feared complications of TAVI, with a relatively low but persistent incidence of 2–4%, without significant reduction over...

ACC 2026 | PRO-TAVI Trial: Deferring Coronary Angioplasty in Patients Undergoing TAVI

Coronary artery disease is common in patients with severe aortic stenosis undergoing TAVI. Current guidelines recommend considering revascularization in significant coronary lesions, particularly in...